| (210) | Number of the EPO application | 15794804 |
| (220) | Filing date of the EPO application | 2015.11.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 24/2021, 2021.06.16 |
| (110) | EPO patent number | 3218487 |
| (21) | Number of the application | e 2017 0082 |
| (71) | Name(s) of applicant(s), code of the country | Alnylam Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | HINKLE Gregory, US;
JADHAV Vasant, US;
MAIER Martin, US;
MANOHARAN Muthiah, US;
MILSTEIN Stuart, US;
SHULGA-MORSKAYA Svetlana, US;
RAJEEV Kallanthottathil G., US;
SEPP-LORENZINO Laura, US;
XU Huilei, US; |
| (73) | Name(s) of owner(s), code of the country | Alnylam Pharmaceuticals, Inc., US; |
| (54) | Title of the invention | HEPATITIS D VIRUS (HDV) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C12N 15/113 (2010.01.01); A61K 31/713 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2017.10.31 |
| (30) | Priority | 201462077799 P, 2014.11.10, US; 201462077672 P, 2014.11.10, US; 201562137464 P, 2015.03.24, US |
| (86) | International application | PCT/US2015/059958, 2015.11.10 |
| (87) | International publication | WO 2016/077349, 2016.05.19 |